Table 2.
Reference | Dietary Intervention(s) | Intervention Period (Age) | Age at Sampling | Effects on Gut Development versus a Control Milk Replacer |
---|---|---|---|---|
[53] | Polydextrose (2 g/L) + Fructo-oligosaccharides (2 g/L) | 1–14 | 7, 14 | Lowers digestive enzyme production at both sampling days: ↓ Lactase, sucrase, disaccharidase and aminopeptidase N activity (ileum) ↓ Dipeptidyl peptidase IV activity (jejunum, ileum) = Small-intestine weight and length = Cytokine expression (ileum) = Faecal consistency |
[61] | Polydextrose (2 g/L) + Galacto-oligosaccharides (2 g/L) | 2–33 | 33 | = Small-intestine weight and length ↓ Total volatile fatty acids (colon, no differences in caecum and faeces) ↑ Dry matter of colon digesta ↓ Dry matter of faeces |
[53] | Galacto-oligosaccharides (2 g/L) + Inulin (2 g/L) | 1–21 | 21 | = Small-intestine weight and length = Immune cell population = Nitric oxide synthase activity = Cytokines IL-6 and TNF-α in blood |
[54] | Galacto-oligosaccharides: 0.8% | 1–26 | 4, 27 | Modulates gut microbial population and improves intestinal morphology and barrier function: ↑ Duodenum villus height, villus area, villus-to-crypt ratio (d4), villus width (d27) ↑ Jejunum villus height (d27) ↓ Caecum pH (d4, no other pH differences) ↑ Caecum butyric acid (d27) ↑ Lactobacillus, bifidobacterium in faeces (d27) ↑ Maltase activity (colon: d4, caecum: d27) ↓ Lactase, sucrase, maltase activity (ileum, d27) ↑ mRNA expression of defensins (colon, d4) ↑ mRNA expression of tight-junction proteins in different segments of the intestine (d4, d27) ↑ Tight-junction protein expression (duodenum, colon, d27) ↑ Secretory IgA from saliva (from d19) |
[62] | Galacto-oligosaccharides: 8 mg/mL | 3–25 | 25 | ↑ Relative large-intestine weight in males, but not females = Small-intestine weight ↓ Haematology and clinical chemistry blood parameters |
[63] | Galacto-oligosaccharides (7 g/L) + milk fat globule membrane-10 (5 g/L) + polydextrose (2.4 g/L) + bovine lactoferrin (0.6 g/L) | 3–33 | 33 | Modulates gut microbiota population and stimulates gut function: = Intestinal weight and length, small-intestinal morphology ↓ Colon area ↑ Parabacteroides, Clostridium IV, Lutispora (colon) ↓ Mogibacterium, Collinsella, Klebsiella, Escherichia-Shigella, Eubacterium, Roseburia (colon) ↑ Lactase activity (jejunum), lactase-to-sucrase activity (duodenum, ileum; no difference in jejunum) = Sucrose activity (in any part) ↑ Vasoactive intestinal peptide expression (ileum) |
[56] | Bovine colostrum | 23–31 | 31 | Reduces colonisation by E. coli and modulates intestinal immune system: ↓ Diarrhoea frequency ↓ E. coli in jejunal and ileal tissue and content in non-inoculated intestinal samples, but not in ETEC F18-inoculated samples ↓ TLR-4 and IL-2 gene expression (jejunal and ileal mucosa) = Ig concentrations in mucosa and plasma |
[55] | VP: palm + rapeseed oil VM: VP + milk fat globule membranes (MFGM) MM: VM + sunflower + milk fat |
2–28 | 7, 28 |
|
[64] | Fat origin: only plant lipids or a half-half mixture of plant and dairy lipids | 2–28 | 33 | = Short-chain fatty acids (faeces) |
[65] | Yeast β-glucans: 5, 50 or 250 mg/L | 2–21 | 7, 21 | = Small-intestine length and weight = Ileal crypt depth, villus height, ascending colon-cuff depth = T cell phenotypes, cytokine gene expression, cell proliferation |
[66] | Wheat: up to 40% | 11–25 1 | 25 | ↓ Relative full stomach weight ↑ Sucrase, maltase ↑ Leukocytes, neutrophils |
[67] | Pectin: 2 g/L or 10 g/L | 2–23 |
|
1 A basal milk replacer was given from Day 3 to Day 11 after birth.